ftInvstr
AAREYDRUGS · Healthcare ₹96.0 +1.28% Mkt Cap ₹272 Cr

AAREYDRUGS

Healthcare Drug Manufacturers - Specialty & Generic
₹96.0
+1.28% today · 30d +14.37%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for AAREYDRUGS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹189 Cr
+75.28% YoY
NET PROFIT
₹2 Cr
+231.29% YoY
OPM
2.07%
-0.25pp YoY
EPS
₹0.55
PE 76.62
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
AAREYDRUGS76.62
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 20
Growth MUTED 35
Profitability AVERAGE 30
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
76.62
P/B
1.84
52W HIGH
₹100.0
OFF HIGH
-4.0%
MKT CAP
₹272 Cr
◉ Active Signals
MACDBullish1.5885
RSI(14)Bearish70.65
Near 52W HighBullish-4.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AAREYDRUGS and at what entry.

Sign up freeSign in